Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
8
89%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
Not yet recruiting2
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
80.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

completed444%
not_yet_recruiting222%
unknown222%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9